Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-24 @ 4:50 PM
NCT ID:
NCT00560950
Eligibility Criteria:
Inclusion Criteria:
* Postmenopausal or negative urine pregnancy test if female
* No fever on the day of vaccination
Exclusion Criteria:
* History of allergy to vaccine components
* History of pneumococcal disease
* Received any live virus vaccination within 4 weeks prior to study start
* Received any inactivated vaccination within 7 days prior to study start
* Received any blood products within 5 months prior to study start
* Participated in an investigational drug or vaccine study in the past 30 days
* Received immunosuppressive therapy
* Patient has an immune deficiency
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
59 Years
Study:
NCT00560950
Study Brief:
Protocol Section:
NCT00560950